| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |